While substantial progress has been made in sharing data from clinical trials, many top-selling medicines still fall short ...

Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma ...

In patients who could not afford new devices on their own, use of so-called "reconditioned" pacemakers met criteria for ...

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases ...

Analyst Keay Nakae from Chardan Capital maintained a Buy rating on Silence Therapeutics (SLN – Research Report) and keeping the price target ... primarily revolving around promising clinical trial ...

Q3 2024 Earnings Call Transcript November 18, 2024 Operator: Good afternoon, ladies and gentlemen, and welcome to the NRx ...

Today, Everest Medicines announced that NEFECON(R) has received full approval from the Ministry of Food and Drug Safety (MFDS) in South Korea, indicated for the treatment of adults with primary ...

Adverum Biotechnologies advances wet AMD treatment with promising trial results. See why ADVM stock has potential as it ...

Six sites across the U.S. are now engaged in Phase1b study Marlborough, Massachusetts--(Newsfile Corp. - November 19, 2024) - Phio ...

Dr. Céline Gounder answers questions about some of the ideas in the sweeping “Make America Healthy Again” platform Robert F.

The series of single arm focused on the safety and efficacy ... New Zealand and Australia. The UK report... at 07:35 Neuron23 Announces Usage of Roche's Digital Biomarker and Device in Parkinson's ...

Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence ...